185 related articles for article (PubMed ID: 7682350)
21. Recruitment of lymphocytes to human liver allografts during rejection.
Hathaway M; Adams DH; Burnett D; Elias E
Transplant Proc; 1990 Oct; 22(5):2306-7. PubMed ID: 2219381
[No Abstract] [Full Text] [Related]
22. [Initial experiences in diagnosis of graft rejection following clinical heart transplantation. Detection of graft-directed activated T-cells].
Werner M; Otto U; Keitel R; Klötzer B; Schürer KD; Walther J; Vogt S; Ambrosius H
Zentralbl Chir; 1990; 115(14):905-12. PubMed ID: 2238967
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic concepts in clinical organ transplantation: histocompatibility testing and T cell monitoring.
Wonigeit K
J Clin Chem Clin Biochem; 1984 Dec; 22(12):959-67. PubMed ID: 6396372
[TBL] [Abstract][Full Text] [Related]
24. Expression of early and late activation markers on peripheral blood T lymphocytes does not reliably reflect immune events in transplanted hearts.
Loertscher R; Forbes RD; Halabi G; Lavery P; Quinn T
Clin Transplant; 1994 Jun; 8(3 Pt 1):230-8. PubMed ID: 8061361
[TBL] [Abstract][Full Text] [Related]
25. Bidirectional modulation of human B cell stimulation by activated T cells.
Hirohata S; Shinohara S
Cell Immunol; 1993 Sep; 150(2):257-68. PubMed ID: 8370072
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of T cell activation by a monoclonal antibody reactive against the alpha 3 domain of human MHC class I molecules.
Smith DM; Bluestone JA; Jeyarajah DR; Newberg MH; Engelhard VH; Thistlethwaite JR; Woodle ES
J Immunol; 1994 Aug; 153(3):1054-67. PubMed ID: 7913109
[TBL] [Abstract][Full Text] [Related]
27. Role of interleukin-2-producing CD4+ T cells in acute rejection of class I major histocompatibility complex disparate rat heart allografts.
Ito T; Stepkowski SM; Shirakura R; Nakata S; Yamamoto S; Nozaki S; Miyata M; Matsuda H
Transplant Proc; 1993 Feb; 25(1 Pt 2):885-7. PubMed ID: 8442257
[No Abstract] [Full Text] [Related]
28. Lymphocyte propagation from biopsies of kidney allografts.
Engstrand M; Larsson E; Naghibi M; Tufveson G; Korsgren O; Johnsson C
Transpl Immunol; 2006 Nov; 16(3-4):215-9. PubMed ID: 17138056
[TBL] [Abstract][Full Text] [Related]
29. The successful use of repeated courses of OKT3 for hepatic allograft rejection using %T3 cells to adjust dose.
Colonna JO; Millis JM; Martello J; Levy P; Iwaki Y; Brems JJ; Klein AS; Hiatt JR; Busuttil RW
Transplant Proc; 1989 Feb; 21(1 Pt 2):2247-8. PubMed ID: 2523600
[No Abstract] [Full Text] [Related]
30. Chagasic patients with indeterminate clinical form of the disease have high frequencies of circulating CD3+CD16-CD56+ natural killer T cells and CD4+CD25High regulatory T lymphocytes.
Vitelli-Avelar DM; Sathler-Avelar R; Dias JC; Pascoal VP; Teixeira-Carvalho A; Lage PS; Elói-Santos SM; Corrêa-Oliveira R; Martins-Filho OA
Scand J Immunol; 2005 Sep; 62(3):297-308. PubMed ID: 16179017
[TBL] [Abstract][Full Text] [Related]
31. Analysis of KIR2D receptors on peripheral blood lymphocytes from liver graft recipients.
López-Alvarez MR; Gómez-Mateo J; Ruiz-Merino G; Campillo JA; Miras M; García-Alonso AM; Sánchez-Bueno F; Parrilla P; Alvarez-López MR; Minguela A
Transpl Immunol; 2006 Dec; 17(1):51-4. PubMed ID: 17157216
[TBL] [Abstract][Full Text] [Related]
32. Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer.
Lefebvre S; Antoine M; Uzan S; McMaster M; Dausset J; Carosella ED; Paul P
J Pathol; 2002 Mar; 196(3):266-74. PubMed ID: 11857488
[TBL] [Abstract][Full Text] [Related]
33. Microcytotoxic HLA typing of cells directly isolated from blood by means of antibody-coated microspheres.
Vartdal F; Bratlie A; Gaudernack G; Funderud S; Lea T; Thorsby E
Transplant Proc; 1987 Feb; 19(1 Pt 1):655-7. PubMed ID: 3152705
[No Abstract] [Full Text] [Related]
34. Phenotypes of in vivo-activated T lymphocytes from a pancreas allograft.
Binimelis J; Sutherland D; Sibley R; de Leiva A; Barbosa J
Transplant Proc; 1987 Feb; 19(1 Pt 1):403. PubMed ID: 3274794
[No Abstract] [Full Text] [Related]
35. Absence of irreversible rejection in the presence of warm anti-donor-HLA class I cytotoxic IgG antibody.
Shoker A; Klassen J; Herbut B
Clin Nephrol; 1997 Feb; 47(2):87-91. PubMed ID: 9049455
[TBL] [Abstract][Full Text] [Related]
36. Devising murine models to better adapt clinical protocols: sequential low-dose treatment with anti-CD3 and anti-CD4 monoclonal antibodies to prevent fully mismatched allograft rejection.
Campos HH; Bach JF; Chatenoud L
Transplant Proc; 1993 Feb; 25(1 Pt 1):798-9. PubMed ID: 8438486
[No Abstract] [Full Text] [Related]
37. Effect of storage time on the analysis of lymphocyte subpopulations in pleural effusions.
Guzman J; Arbogast S; Bross KJ; Finke R; Costabel U
Acta Cytol; 1993; 37(3):267-71. PubMed ID: 7684547
[TBL] [Abstract][Full Text] [Related]
38. Role of T-cell subsets in rat liver allograft rejection.
Yokoi Y; Sumimoto R; Yamaguchi A; Baba S; Nakamura S; Kimura H
Transplant Proc; 1993 Apr; 25(2):1994-6. PubMed ID: 8470255
[No Abstract] [Full Text] [Related]
39. Histoincompatibility-associated differences in the phenotypes of murine cardiac allograft infiltrating T cells.
Carlquist JF; Shelby J; Hammond EH; Greenwood JH; Anderson JL
Immunology; 1994 May; 82(1):149-53. PubMed ID: 7913913
[TBL] [Abstract][Full Text] [Related]
40. Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes.
Heeger PS; Greenspan NS; Kuhlenschmidt S; Dejelo C; Hricik DE; Schulak JA; Tary-Lehmann M
J Immunol; 1999 Aug; 163(4):2267-75. PubMed ID: 10438971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
